Evaluation of an Accelerated Body-whole Bone CT Procedure With the CZT(Cadmium-Zinc-Telluride) "VERITON-CT ™" Camera
OSS
1 other identifier
interventional
146
1 country
2
Brief Summary
The purpose of the OSS study is to evaluate a procedure involving a single full body SPECT/CT (Single photon emission computed tomography coupled with a computerized tomography) 3D recording with a new semiconductor camera,his name is VERITON-CT ™ (Spectrum Dynamics Medical). This recording can be done in less than 25 minutes due to an original system of CZT (Cadmium-Zinc-Telluride) detectors allowing to increase the quality of the images and especially, to multiply by a factor 2 to 3 the detection sensitivity. This camera is also equipped with a scanner capable of obtaining a body-to-integer recording with a low level of irradiation (≤ 2 mSv)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2020
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2019
CompletedFirst Posted
Study publicly available on registry
November 8, 2019
CompletedStudy Start
First participant enrolled
February 4, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 4, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2023
CompletedJune 25, 2026
June 1, 2024
2.4 years
November 6, 2019
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
concordance between the two procedures
Concordance between the 2 procedures of the importance of scintigraphic abnormalities evoking a neoplastic process and which will be classified into 3 categories (these categories may correspond to different medical and therapeutic care) : 1) absence of any suspicious focus, 2) 1 or 2 metastases 3) more than 2 metastases
half hour
Secondary Outcomes (1)
concordance between the two procedures 3D
half hour
Study Arms (2)
group 1 in pair week
EXPERIMENTALIn pair week, patients will be included in group1:a conventional recording with SPECT/CT will be realized in first time
group 2 in odd week
EXPERIMENTALIn odd week, patients will be included in group2: a 25 minutes recording 3D in camera VERITON-CT ™ will be realized in first time
Interventions
The procedure of recording of 25 minutes in camera VERITON-CT ™ including the registration whole body 3D coupled to a scanner low dose (CT) will be added to conventional recording followed by complementary images SPECT/CT in the second time for the group 1 and in the first time for the group 2
Eligibility Criteria
You may qualify if:
- Patient having read and understood the information document and having signed the consent.
- Patient referred for bone scintigraphy to detect possible metastatic or primary neoplastic lesions (known neoplastic antecedent), or for assessment and / or follow-up of known neoplastic bone lesions
- Patient agreeing to perform the additional 25 minutes of recording with the VERITON-CT ™ camera.
- Patient being affiliated to a social security scheme
You may not qualify if:
- A woman who is pregnant or of childbearing age and without suitable contraceptive means
- No signature of the informed consent form by the patient.
- Unstable medical condition and / or inability to remain still in the supine position during the recordings
- Person with a known allergy to one of the components of the radiotracer (TECHNESCAN HDP).
- Person deprived of liberty by a judicial or administrative decision.
- Major person subject to a legal protection measure (guardianship, curatorship, safeguard of justice).
- Major person unable to express consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Central Hospital, Nancy, Francelead
- GIE NANCYCLOTEPcollaborator
Study Sites (2)
Service de Médecine Nucléaire - CHRU de Nancy-Brabois
Vandœuvre-lès-Nancy, 54511, France
Veronique Roch
Vandœuvre-lès-Nancy, 54511, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinicipal Investigator
Study Record Dates
First Submitted
November 6, 2019
First Posted
November 8, 2019
Study Start
February 4, 2020
Primary Completion
July 4, 2022
Study Completion
March 2, 2023
Last Updated
June 25, 2026
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share